Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation.
BACKGROUND
Most of what is known about the Helicobacter pylori (H. pylori) cytotoxin, CagA, pertains to a much-vaunted role as a determinant of gastric inflammation and cancer. Little attention has been devoted to potential roles of CagA in the majority of H. pylori infected individuals not showing oncogenic progression, particularly in relation to host tolerance. Regenerating islet-derived (REG)3γ encodes a secreted C-type lectin that exerts direct bactericidal activity against Gram-positive bacteria in the intestine. Here, we extend this paradigm of lectin-mediated innate immunity, showing that REG3γ expression is triggered by CagA in the H. pylori-infected stomach.


RESULTS
In human gastric mucosal tissues, REG3γ expression was significantly increased in CagA-positive, compared to CagA-negative H. pylori infected individuals. Using transfected CagA-inducible gastric MKN28 cells, we recapitulated REG3γ induction in vitro, also showing that tyrosine phosphorylated, not unphosphorylated CagA triggers REG3γ transcription. In concert with induced REG3γ, pro-inflammatory signalling downstream of the gp130 cytokine co-receptor via the signal transducer and activator of transcription (STAT)3 and transcription of two cognate ligands, interleukin(IL)-11 and IL-6, were significantly increased. Exogenous IL-11, but not IL-6, directly stimulated STAT3 activation and REG3γ transcription. STAT3 siRNA knockdown or IL-11 receptor blockade respectively abrogated or subdued CagA-dependent REG3γ mRNA induction, thus demonstrating a requirement for uncompromised signalling via the IL-11/STAT3 pathway. Inhibition of the gp130-related SHP2-(Ras)-ERK pathway did not affect CagA-dependent REG3γ induction, but strengthened STAT3 activation as well as augmenting transcription of mucosal innate immune regulators, IL-6, IL-8 and interferon-response factor (IRF)1.


CONCLUSIONS
Our results support a model of CagA-directed REG3γ expression in gastric epithelial cells via activation of the IL-11/gp130/STAT3 pathway. This response might allow Gram-negative H. pylori to manipulate host immunity to favour its own survival, by reducing the fitness of co-habiting Gram-positive bacteria with which it competes for resources in the gastric mucosal niche.
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.
Kai Syin
KS
Lee
Anastasia
A
Kalantzis
Cameron B
CB
Jackson
Louise
L
O'Connor
Naoko
N
Murata-Kamiya
Masanori
M
Hatakeyama
Louise M
LM
Judd
Andrew S
AS
Giraud
Trevelyan R
TR
Menheniott
D000942:Antigens, Bacterial / Q000737:chemistry / Q000378:metabolism*; D001426:Bacterial Proteins / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D050822:Cytokine Receptor gp130 / Q000378:metabolism; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism / Q000382:microbiology; D005753:Gastric Mucosa / Q000166:cytology / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology*; D005786:Gene Expression Regulation; D016480:Helicobacter pylori / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D017370:Interleukin-11 / Q000378:metabolism; D053612:Janus Kinases / Q000378:metabolism; D020935:MAP Kinase Signaling System; D000073718:Pancreatitis-Associated Proteins; D010766:Phosphorylation; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014443:Tyrosine / Q000378:metabolism
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D017370:Interleukin-11; D000073718:Pancreatitis-Associated Proteins; D011506:Proteins; C494437:REG3G protein, human; D012333:RNA, Messenger; D050796:STAT3 Transcription Factor; C080866:cagA protein, Helicobacter pylori; D050822:Cytokine Receptor gp130; D014443:Tyrosine; D053612:Janus Kinases